HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today an agreement between SpinalCyte and Howard An, M.D., The Morton International Endowed Chair Professor of Orthopaedic Surgery & Director, Division of Spine Surgery and Spine Fellowship Program, Rush University Medical Center to complete the final animal trials.
Help employers find you! Check out all the jobs and post your resume.
